Bluebird bio earnings
WebFeb 23, 2024 · bluebird bio (NASDAQ:BLUE) Q4 2024 results missed analyst estimates on both EPS and revenue.; Revenue increased modestly quarter over quarter from $10M to $10M and the EPS loss narrowed to ($3.01 ... WebAug 4, 2024 · Bluebird Bio (BLUE) came out with a quarterly loss of $1.29 per share versus the Zacks Consensus Estimate of a loss of $1.31. This compares to loss of $3.58 per share a year ago. These figures are ...
Bluebird bio earnings
Did you know?
WebBluebird Bio (BLUE) reports earnings on 6/28/2024. Shares are down 15.8% since reporting last quarter. The Earnings Whisper Score gives the statistical odds for the … WebApr 13, 2024 · bluebird bio Inc ( BLUE) is up 3.23% today. BLUE has an Overall Score of 52. Find out what this means to you and get the rest of the rankings on BLUE! BLUE stock closed at $2.79 and is up $0.09 during pre-market trading. Pre-market tends to be more volatile due to significantly lower volume as most investors only trade between standard …
WebFeb 9, 2024 · Bluebird Bio (BLUE) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2024. This widely-known consensus outlook ... WebMar 4, 2024 · bluebird bio Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Operational Progress February 23, 2024 - … Results and Highlights Operational Progress 02/23/21 Earnings CAMBRIDGE, Mass. --(BUSINESS WIRE)- …
WebApr 3, 2024 · Wedbush analyst D. Nierengarten now expects that the biotechnology company will earn ($0.76) per share for the quarter, down from their prior forecast of ($0.60). The consensus estimate for bluebird bio's current full-year earnings is ($2.62) per share. WebAug 9, 2024 · Bluebird Bio, Inc. (NASDAQ:NASDAQ:BLUE) Q2 2024 Earnings Conference Call August 9, 2024 8:00 AM ETCompany ParticipantsNick Leschly – Chief Executive OfficerElizabeth Pingpank – Direct...
WebApr 14, 2024 · With the market capitalization of bluebird bio Inc. currently standing at about $344.49 million, investors are eagerly awaiting this quarter’s results, scheduled for May 08, 2024 – May 12, 2024. As a result, investors might want to see an improvement in the stock’s price before the company announces its earnings report.
WebApr 14, 2024 · Cookson Peirce & Co. Inc. purchased a new position in bluebird bio, Inc. (NASDAQ:BLUE – Get Rating) during the 4th quarter, according to its most recent filing … shop sabre dust bootWebApr 5, 2024 · bluebird bio GAAP EPS of -$0.38 misses by $0.18, revenue of $0.06M misses by $15.34M SA News Wed, Mar. 29 1 Comment Earnings history by period FQ3 … shopsabre nationWebMar 27, 2024 · bluebird bio, Inc. ( NASDAQ:BLUE - Get Rating) - Investment analysts at William Blair issued their FY2024 earnings per share (EPS) estimates for shares of bluebird bio in a report released on Wednesday, March 22nd. William Blair analyst S. Corwin forecasts that the biotechnology company will post earnings of ($4.73) per share … shop sabre is-510WebNov 8, 2024 · As of Sep 30, 2024, BLUE raised approximately $54.1 million in net proceeds through its At-the-Market (ATM) equity facility. Of this $54.1 million, $46.1 million in net … shop sabre is612WebMar 29, 2024 · Bluebird , which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $0.06 million for the quarter ended December 2024, missing … shopsabre f1 \\u0026 f4 single phase vacuum pumpWeb1 day ago · bluebird bio, Inc. (NASDAQ:BLUE) Bluebird Bio signaled a delay in its sickle cell disease drug application to the FDA in its Q4 earnings release. The company’s stock has a 52-week low of $2.78. shopsabre is 612WebMay 3, 2024 · Bluebird Bio (BLUE) is expected to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended March 2024. shopsabre plasma reviews